Human medicines European public assessment report EPAR Hulio adalimumab Hidradenitis SuppurativaPsoriasisCrohn DiseaseUveitisArthritis RheumatoidColitis UlcerativeSpondylitis AnkylosingArthritis Psoriatic Date of authorisation 16092018

Human medicines European public assessment report EPAR Hulio adalimumab Hidradenitis SuppurativaPsoriasisCrohn DiseaseUveitisArthritis RheumatoidColitis UlcerativeSpondylitis AnkylosingArthritis Psoriatic Date of authorisation 16092018 Revision 1 Status Au...